F. Ferris, S. Fine, and L. Hyman, Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy, Archives of Ophthalmology, vol.102, issue.11, pp.1640-1642, 1960.
DOI : 10.1001/archopht.1984.01040031330019

T. Wong, T. Wong, U. Chakravarthy, R. Klein, P. Mitchell et al., The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration, Ophthalmology, vol.115, issue.1, pp.116-142, 2008.
DOI : 10.1016/j.ophtha.2007.03.008

C. Augood, J. Vingerling, P. De-jong, U. Chakravarthy, J. Seland et al., Prevalence of Age-Related Maculopathy in Older Europeans, Archives of Ophthalmology, vol.124, issue.4, pp.529-564, 1960.
DOI : 10.1001/archopht.124.4.529

R. Klein, B. Klein, and K. Linton, Prevalence of age-related maculopathy. The Beaver Dam Eye Study, Ophthalmology, vol.99299, issue.6, pp.933-976
DOI : 10.1016/s0161-6420(92)31871-8

R. Klein, B. Klein, S. Jensen, and S. Meuer, The Five-year Incidence and Progression of Age-related Maculopathy, Ophthalmology, vol.104, issue.1, pp.7-21, 1997.
DOI : 10.1016/S0161-6420(97)30368-6

R. Klein, B. Klein, S. Tomany, S. Meuer, and G. Huang, Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study1 1The authors have no proprietary interest in the products or devices mentioned herein., Ophthalmology, vol.109, issue.10, pp.1767-79, 2002.
DOI : 10.1016/S0161-6420(02)01146-6

H. Buch, T. Vinding, and N. Nielsen, Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population The Copenhagen City Eye Study, Ophthalmology, vol.108, issue.12, pp.2347-57, 2001.
DOI : 10.1016/S0161-6420(01)00823-5

L. Xu, Y. Wang, Y. Li, Y. Wang, T. Cui et al., Causes of Blindness and Visual Impairment in Urban and Rural Areas in Beijing, Ophthalmology, vol.113, issue.7, pp.1134-1135, 2006.
DOI : 10.1016/j.ophtha.2006.01.035

A. Iwase, M. Araie, A. Tomidokoro, T. Yamamoto, H. Shimizu et al., Prevalence and Causes of Low Vision and Blindness in a Japanese Adult Population, Ophthalmology, vol.113, issue.8
DOI : 10.1016/j.ophtha.2006.04.022

W. Mathenge, H. Kuper, H. Limburg, S. Polack, O. Onyango et al., Rapid Assessment of Avoidable Blindness in Nakuru District, Kenya, Ophthalmology, vol.114, issue.3, pp.599-605, 2007.
DOI : 10.1016/j.ophtha.2006.06.057

J. Gass, Drusen and Disciform Macular Detachment and Degeneration, Archives of Ophthalmology, vol.90, issue.3, pp.409-445, 1972.
DOI : 10.1001/archopht.1973.01000050208006

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310465/pdf

J. Seddon, J. Cote, W. Page, S. Aggen, and M. Neale, The US Twin Study of Age-Related Macular Degeneration, Archives of Ophthalmology, vol.123, issue.3, pp.321-328, 1960.
DOI : 10.1001/archopht.123.3.321

R. Klein, C. Zeiss, E. Chew, J. Tsai, R. Sackler et al., Complement Factor H Polymorphism in Age-Related Macular Degeneration, Science, vol.308, issue.5720, pp.385-394, 2005.
DOI : 10.1126/science.1109557

E. Souied, N. Leveziel, F. Richard, M. Dragon-durey, G. Coscas et al., Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population, Mol Vis, vol.11, pp.1135-1175, 2005.

D. Schaumberg, S. Hankinson, Q. Guo, E. Rimm, and D. Hunter, A prospective study

A. Rivera, S. Fisher, L. Fritsche, C. Keilhauer, P. Lichtner et al., Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk, Human Molecular Genetics, vol.14, issue.21, pp.3227-3263, 2005.
DOI : 10.1093/hmg/ddi353

M. Klein, P. Francis, B. Rosner, R. Reynolds, S. Hamon et al., CFH and LOC387715/ARMS2 Genotypes and Treatment with Antioxidants and Zinc for Age-Related Macular Degeneration, Ophthalmology, vol.115, issue.6, pp.1019-1044, 2008.
DOI : 10.1016/j.ophtha.2008.01.036

M. Brantley, A. Fang, J. King, A. Tewari, S. Kymes et al., Association of Complement Factor H and LOC387715 Genotypes with Response of Exudative Age-Related Macular Degeneration to Intravitreal Bevacizumab, Ophthalmology, vol.114, issue.12, pp.2168-73, 2007.
DOI : 10.1016/j.ophtha.2007.09.008

A. Lee, A. Raya, S. Kymes, A. Shiels, and M. Brantley, Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab, British Journal of Ophthalmology, vol.93, issue.5, pp.610-613, 2009.
DOI : 10.1136/bjo.2008.150995

F. Abedi, S. Wickremasinghe, A. Richardson, A. Islam, R. Guymer et al., Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration, Ophthalmology, vol.120, issue.8, pp.1641-1649, 2013.
DOI : 10.1016/j.ophtha.2013.01.014

V. Dedania, S. Grob, K. Zhang, and S. Bakri, PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.3, pp.381-91, 2015.
DOI : 10.1097/IAE.0000000000000466

Z. Hu, P. Xie, Y. Ding, D. Yuan, and Q. Liu, Association between variants A69S in ARMS2 gene and response to treatment of exudative AMD: a meta-analysis, British Journal of Ophthalmology, vol.127, issue.5, pp.593-601, 2015.
DOI : 10.1007/s00439-010-0805-8

J. Seddon, P. Francis, S. George, D. Schultz, B. Rosner et al., Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular Degeneration, JAMA, vol.297, issue.16, pp.1793-800, 2007.
DOI : 10.1001/jama.297.16.1793

C. Delcourt, A. Lacroux, I. Carrière, . Pola-study, and . Group, The Three-Year Incidence of Age-Related Macular Degeneration: The ???Pathologies Oculaires Li??es ?? l???Age??? (POLA) Prospective Study, American Journal of Ophthalmology, vol.140, issue.5, pp.924-930, 2005.
DOI : 10.1016/j.ajo.2005.05.002

F. Ferris, M. Davis, T. Clemons, L. Lee, E. Chew et al., A simplified severity scale for age-related macular degeneration: AREDS Report No. 18, Arch Ophthalmol Chic Ill, vol.123, issue.11, pp.1570-1574, 1960.

R. Klein, T. Peto, A. Bird, and M. Vannewkirk, The epidemiology of age-related macular degeneration, American Journal of Ophthalmology, vol.137, issue.3, pp.486-95, 2004.
DOI : 10.1016/j.ajo.2003.11.069

R. Klein, B. Klein, M. Knudtson, T. Wong, M. Cotch et al., Prevalence of Age-Related Macular Degeneration in 4 Racial/Ethnic Groups in the Multi-ethnic Study of Atherosclerosis, Ophthalmology, vol.113, issue.3, pp.373-80, 2006.
DOI : 10.1016/j.ophtha.2005.12.013

J. Thornton, R. Edwards, P. Mitchell, R. Harrison, I. Buchan et al., Smoking and agerelated macular degeneration: a review of association, Eye Lond Engl, vol.19, issue.9, pp.935-979, 2005.

P. Francis, S. George, D. Schultz, B. Rosner, S. Hamon et al., The <i>LOC387715 </i>Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration, Human Heredity, vol.63, issue.3-4, pp.212-220, 2007.
DOI : 10.1159/000100046

J. Sangiovanni, E. Chew, T. Clemons, M. Davis, F. Ferris et al., The relationship of dietary lipid intake and age-related macular degeneration in a case-control study, AREDS Report No. Arch Ophthalmol Chic Ill, vol.20125, issue.5, pp.671-680, 1960.

A. Bird, The Bowman lecture. Towards an understanding of age-related macular disease, Eye Lond Engl, vol.17, issue.4, pp.457-66, 2003.

J. Ambati, B. Ambati, S. Yoo, S. Ianchulev, and A. Adamis, Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies, Survey of Ophthalmology, vol.48, issue.3, pp.257-93, 2003.
DOI : 10.1016/S0039-6257(03)00030-4

J. Seddon, G. Gensler, R. Milton, M. Klein, and N. Rifai, Association Between C-Reactive Protein and Age-Related Macular Degeneration, JAMA, vol.291, issue.6, pp.704-714, 2004.
DOI : 10.1001/jama.291.6.704

URL : http://jama.jamanetwork.com/data/journals/jama/4915/joc31989.pdf

K. Kimura, Y. Isashiki, S. Sonoda, T. Kakiuchi-matsumoto, and N. Ohba, Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration, American Journal of Ophthalmology, vol.130, issue.6, pp.769-73, 2000.
DOI : 10.1016/S0002-9394(00)00552-3

P. Penfold, M. Madigan, M. Gillies, and J. Provis, Immunological and Aetiological Aspects of Macular Degeneration, Progress in Retinal and Eye Research, vol.20, issue.3, pp.385-414, 2001.
DOI : 10.1016/S1350-9462(00)00025-2

D. Anderson, R. Mullins, G. Hageman, and L. Johnson, A role for local inflammation in the formation of drusen in the aging eye, American Journal of Ophthalmology, vol.134, issue.3, pp.411-442, 2002.
DOI : 10.1016/S0002-9394(02)01624-0

G. Hageman, P. Luthert, V. Chong, N. Johnson, L. Anderson et al., An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration, Progress in Retinal and Eye Research, vol.20, issue.6, pp.705-737, 2001.
DOI : 10.1016/S1350-9462(01)00010-6

G. Yancopoulos, S. Davis, N. Gale, J. Rudge, S. Wiegand et al., Vascular-specific growth factors and blood vessel formation, Nature, vol.407, issue.6801, pp.242-250, 2000.
DOI : 10.1038/35025215

S. Boyd, I. Zachary, U. Chakravarthy, G. Allen, G. Wisdom et al., Correlation of Increased Vascular Endothelial Growth Factor With Neovascularization and Permeability in Ischemic Central Vein Occlusion, Archives of Ophthalmology, vol.120, issue.12, pp.1644-50, 1960.
DOI : 10.1001/archopht.120.12.1644

N. Ogata, M. Nishikawa, T. Nishimura, Y. Mitsuma, and M. Matsumura, Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy, American Journal of Ophthalmology, vol.134, issue.3, pp.348-53, 2002.
DOI : 10.1016/S0002-9394(02)01568-4

T. Ishibashi, Y. Hata, H. Yoshikawa, K. Nakagawa, K. Sueishi et al., Expression of vascular endothelial growth factor in experimental choroidal neovascularization, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.80, issue.3, pp.159-67, 1997.
DOI : 10.1007/BF00941723

M. Kliffen, H. Sharma, C. Mooy, S. Kerkvliet, and P. De-jong, Increased expression of angiogenic growth factors in age-related maculopathy, British Journal of Ophthalmology, vol.81, issue.2, pp.154-62, 1997.
DOI : 10.1136/bjo.81.2.154

A. Kvanta, P. Algvere, L. Berglin, and S. Seregard, Subfoveal fibrovascular membranes in agerelated macular degeneration express vascular endothelial growth factor, Invest Ophthalmol Vis Sci, vol.37, issue.9, pp.1929-1963, 1996.
DOI : 10.1016/s0002-9394(14)70522-7

P. Campochiaro, Retinal and choroidal neovascularization, Journal of Cellular Physiology, vol.235, issue.3, pp.301-311, 2000.
DOI : 10.1002/(SICI)1097-4652(199905)179:2<149::AID-JCP5>3.0.CO;2-2

A. Giovannini, G. Amato, C. Mariotti, and B. Scassellati-sforzolini, OCT imaging of choroidal neovascularisation and its role in the determination of patients' eligibility for surgery, British Journal of Ophthalmology, vol.83, issue.4, pp.438-480, 1999.
DOI : 10.1136/bjo.83.4.438

K. Freund, S. Zweifel, and E. M. , Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina Phila Pa, pp.1333-1382, 2010.

P. Stanga, J. Lim, and P. Hamilton, Indocyanine green angiography in chorioretinal diseases: indications and interpretation, Ophthalmology, vol.110, issue.1, pp.15-21, 2003.
DOI : 10.1016/S0161-6420(02)01563-4

F. Sulzbacher, C. Kiss, M. Munk, G. Deak, S. Sacu et al., Diagnostic Evaluation of Type 2 (Classic) Choroidal Neovascularization: Optical Coherence Tomography, Indocyanine Green Angiography, and Fluorescein Angiography, American Journal of Ophthalmology, vol.152, issue.5, pp.799-806, 2011.
DOI : 10.1016/j.ajo.2011.04.011

K. Freund, I. Ho, I. Barbazetto, H. Koizumi, K. Laud et al., TYPE 3 NEOVASCULARIZATION, Retina, vol.28, issue.2, pp.201-212, 2008.
DOI : 10.1097/IAE.0b013e3181669504

L. Yannuzzi, K. Freund, and B. Takahashi, Review of Retinal Angiomatous Proliferation or Type 3 Neovascularization, Retina, vol.28, issue.3, pp.375-84, 2008.
DOI : 10.1097/IAE.0b013e3181619c55

L. Yannuzzi, S. Negrão, T. Iida, C. Carvalho, H. Rodriguez-coleman et al., RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION, Retina, vol.21, issue.5, pp.416-450, 2001.
DOI : 10.1097/00006982-200110000-00003

J. Gass, A. Agarwal, A. Lavina, and K. Tawansy, Focal Inner Retinal Hemorrhages in Patients with Drusen, RETINA, vol.23, issue.6, pp.741-51, 2003.
DOI : 10.1097/00006982-200312000-00001

A. Polito, M. Isola, P. Lanzetta, D. Gregori, and F. Bandello, The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review, Ann Acad Med Singapore, vol.35, issue.3, pp.145-50, 2006.

G. Soubrane, G. Coscas, C. Français, and F. Koenig, Occult Subretinal New Vessels in Age-related Macular Degeneration, Ophthalmology, vol.97, issue.5, pp.649-57, 1990.
DOI : 10.1016/S0161-6420(90)32530-7

J. Gass, R. Sever, D. Sparks, J. Goren, G. Coscas et al., A combined technique of fluorescein funduscopy and agiography of the eye Macular degeneration related to age and cystoid macular edema. Apropos of 95 cases (100 eyes), Arch Ophthalmol Chic Ill J Fr Ophtalmol, vol.7811, issue.411, pp.711-731, 1960.

N. Gross, A. Aizman, A. Brucker, J. Klancnik, and L. Yannuzzi, NATURE AND RISK OF NEOVASCULARIZATION IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL RETINAL ANGIOMATOUS PROLIFERATION, Retina, vol.25, issue.6, pp.713-721, 2005.
DOI : 10.1097/00006982-200509000-00005

D. Kuhn, I. Meunier, G. Soubrane, and G. Coscas, Imaging of Chorioretinal Anastomoses in Vascularized Retinal Pigment Epithelium Detachments, Archives of Ophthalmology, vol.113, issue.11, pp.1392-1400, 1960.
DOI : 10.1001/archopht.1995.01100110052025

G. Querques, K. Atmani, E. Berboucha, D. Martinelli, G. Coscas et al., ANGIOGRAPHIC ANALYSIS OF RETINAL???CHOROIDAL ANASTOMOSIS BY CONFOCAL SCANNING LASER OPHTHALMOSCOPY TECHNOLOGY AND CORRESPONDING (EYE-TRACKED) SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY, Retina, vol.30, issue.2, pp.222-256, 2010.
DOI : 10.1097/IAE.0b013e3181bceef0

J. Hwang, D. Priore, L. Freund, K. Chang, S. Iranmanesh et al., Development of Subretinal Fibrosis After Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration, Ophthalmic Surgery, Lasers, and Imaging, vol.42, issue.1, pp.6-11, 2011.
DOI : 10.3928/15428877-20100924-01

S. Bloch, H. Lund-andersen, B. Sander, and M. Larsen, Subfoveal Fibrosis in Eyes With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab, American Journal of Ophthalmology, vol.156, issue.1, pp.116-124, 2013.
DOI : 10.1016/j.ajo.2013.02.012

R. Channa, R. Sophie, S. Bagheri, S. Shah, J. Wang et al., Regression of Choroidal Neovascularization Results in Macular Atrophy in Anti-Vascular Endothelial Growth Factor-Treated Eyes, American Journal of Ophthalmology, vol.159, issue.1, pp.9-19, 2015.
DOI : 10.1016/j.ajo.2014.09.012

L. Toth, M. Stevenson, and U. Chakravarthy, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.10, pp.1957-63, 2015.
DOI : 10.1097/IAE.0000000000000583

S. Cohen, H. Oubraham, J. Uzzan, L. Dubois, and R. Tadayoni, CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS, Retina, vol.32, issue.8, pp.1480-1485, 2012.
DOI : 10.1097/IAE.0b013e318240a516

P. Rosenfeld, H. Shapiro, L. Tuomi, M. Webster, J. Elledge et al., Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials, Ophthalmology, vol.118, issue.3, pp.523-553, 2011.
DOI : 10.1016/j.ophtha.2010.07.011

S. Zweifel, M. Engelbert, K. Laud, R. Margolis, R. Spaide et al., Outer Retinal Tubulation, Archives of Ophthalmology, vol.127, issue.12, pp.1596-602, 1960.
DOI : 10.1001/archophthalmol.2009.326

M. Kramer, K. Mimouni, E. Priel, Y. Yassur, and D. Weinberger, Comparison of fluorescein angiography and indocyanine green angiography for imaging of choroidal neovascularization in hemorrhagic age-related macular degeneration, American Journal of Ophthalmology, vol.129, issue.4, pp.495-500, 2000.
DOI : 10.1016/S0002-9394(99)00388-8

C. Delcourt, J. Cristol, F. Tessier, C. Léger, B. Descomps et al., Age-related Macular Degeneration and Antioxidant Status in the POLA Study, Archives of Ophthalmology, vol.117, issue.10, pp.1384-90, 1960.
DOI : 10.1001/archopht.117.10.1384

J. Tan, J. Wang, V. Flood, E. Rochtchina, W. Smith et al., Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration, Ophthalmology, vol.115, issue.2
DOI : 10.1016/j.ophtha.2007.03.083

J. Tan, J. Wang, V. Flood, and P. Mitchell, Dietary Fatty Acids and the 10-Year Incidence of Age-Related Macular Degeneration, Archives of Ophthalmology, vol.127, issue.5, pp.656-65, 1960.
DOI : 10.1001/archophthalmol.2009.76

W. Christen, R. Glynn, E. Chew, C. Albert, and J. Manson, Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women, Archives of Internal Medicine, vol.169, issue.4, pp.335-376, 2009.
DOI : 10.1001/archinternmed.2008.574

R. Bone, J. Landrum, S. Mayne, C. Gomez, S. Tibor et al., Macular pigment in donor eyes with and without AMD: a case-control study, Invest Ophthalmol Vis Sci, vol.42, issue.1, pp.235-275, 2001.

S. Beatty, H. Koh, M. Phil, D. Henson, and M. Boulton, The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration, Survey of Ophthalmology, vol.45, issue.2, pp.115-149, 2000.
DOI : 10.1016/S0039-6257(00)00140-5

B. Hammond, B. Wooten, and D. Snodderly, Preservation of visual sensitivity of older subjects: association with macular pigment density, Invest Ophthalmol Vis Sci, vol.39, issue.2, pp.397-406, 1998.

. Age-related-eye-disease-study-research-group, J. Sangiovanni, E. Chew, T. Clemons, F. Ferris et al., The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22, Arch Ophthalmol Chic Ill, vol.125, issue.9, pp.1225-1257, 1960.

S. Richer, W. Stiles, L. Statkute, J. Pulido, J. Frankowski et al., Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial), Optometry - Journal of the American Optometric Association, vol.75, issue.4, pp.216-246, 2004.
DOI : 10.1016/S1529-1839(04)70049-4

J. Sangiovanni, E. Chew, E. Agrón, T. Clemons, F. Ferris et al., The Relationship of Dietary ??-3 Long-Chain Polyunsaturated Fatty Acid Intake With Incident Age-Related Macular Degeneration, Archives of Ophthalmology, vol.126, issue.9, pp.1274-1283, 1960.
DOI : 10.1001/archopht.126.9.1274

J. Sangiovanni, E. Agrón, A. Meleth, G. Reed, R. Sperduto et al., ??-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study, American Journal of Clinical Nutrition, vol.90, issue.6, pp.1601-1608, 2009.
DOI : 10.3945/ajcn.2009.27594

E. Souied, C. Delcourt, G. Querques, A. Bassols, M. B. Zourdani et al., Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration, Ophthalmology, vol.120, issue.8, pp.1619-1650, 2013.
DOI : 10.1016/j.ophtha.2013.01.005

G. Coscas and G. Soubrane, Argon laser photocoagulation of subretinal neovascularization in senile macular degeneration. Results of a randomized study of 60 cases], Bull Mem Soc Fr Ophtalmol, vol.94, pp.149-54, 1982.

N. Bressler and T. Of, Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2, Arch Ophthalmol Chic Ill, vol.119, issue.2, pp.198-207, 1960.

P. Kaiser, V. I. Occult, and C. , Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial, Current Medical Research and Opinion, vol.25, issue.8, pp.1853-60, 2009.
DOI : 10.1185/03007990903038616

D. Amico, H. Masonson, M. Patel, A. Adamis, and E. Cunningham, Clinical Trial Group Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials, Ophthalmology, vol.113, issue.6, pp.992-1001, 2006.

P. Rosenfeld, D. Brown, J. Heier, D. Boyer, P. Kaiser et al., Ranibizumab for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine, vol.355, issue.14, pp.1419-1450, 2006.
DOI : 10.1056/NEJMoa054481

D. Brown, P. Kaiser, M. Michels, G. Soubrane, J. Heier et al., Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine, vol.355, issue.14, pp.1432-1476, 2006.
DOI : 10.1056/NEJMoa062655

. Catt-research-group, D. Martin, M. Maguire, G. Ying, J. Grunwald et al., Ranibizumab and bevacizumab for neovascular age-related macular degeneration, N Engl J Med, vol.364, issue.20, pp.1897-908, 2011.

C. Group, D. Martin, M. Maguire, S. Fine, G. Ying et al., Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Ophthalmology, vol.119, issue.7, pp.1388-98, 2012.

S. Solomon, K. Lindsley, M. Krzystolik, S. Vedula, and B. Hawkins, Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration, Ophthalmology, vol.123, issue.1, pp.70-77, 2016.
DOI : 10.1016/j.ophtha.2015.09.002

S. Johnston, K. Wilson, A. Huang, D. Smith, H. Varker et al., Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration, Advances in Therapy, vol.45, issue.6, pp.1111-1138, 2013.
DOI : 10.1016/0895-4356(92)90133-8

J. Talks, A. Lotery, F. Ghanchi, S. Sivaprasad, R. Johnston et al., First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration, Ophthalmology, vol.123, issue.2, pp.337-380, 2016.
DOI : 10.1016/j.ophtha.2015.09.039

S. Cohen, B. Maloberti, F. Fajnkuchen, S. Nghiem-buffet, C. Delahaye-mazza et al., Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration, Ophthalmologica, vol.231, issue.2, pp.80-85, 2014.
DOI : 10.1159/000356401

T. Lushchyk, S. Amarakoon, J. Martinez-ciriano, L. Van-den-born, G. Baarsma et al., Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4???weeks, 6???weeks and 8???weeks, Acta Ophthalmologica, vol.118, issue.6, pp.456-461, 2013.
DOI : 10.1016/j.ophtha.2010.09.004

G. Lalwani, P. Rosenfeld, A. Fung, S. Dubovy, S. Michels et al., A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study, American Journal of Ophthalmology, vol.148, issue.1, pp.43-58, 2009.
DOI : 10.1016/j.ajo.2009.01.024

F. Holz, W. Amoaku, J. Donate, R. Guymer, U. Kellner et al., Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study, Ophthalmology, vol.118, issue.4, pp.663-71, 2011.
DOI : 10.1016/j.ophtha.2010.12.019

H. Dadgostar, A. Ventura, J. Chung, S. Sharma, and P. Kaiser, Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration, Ophthalmology, vol.116, issue.9, pp.1740-1747, 2009.
DOI : 10.1016/j.ophtha.2009.05.033

S. Cohen, L. Dubois, R. Tadayoni, F. Fajnkuchen, S. Nghiem-buffet et al., Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting, American Journal of Ophthalmology, vol.148, issue.3, pp.409-422, 2009.
DOI : 10.1016/j.ajo.2009.04.001

R. Spaide, Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration, American Journal of Ophthalmology, vol.143, issue.4, pp.679-80, 2007.
DOI : 10.1016/j.ajo.2007.02.024

R. Spaide, The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System, American Journal of Ophthalmology, vol.148, issue.1, pp.1-3, 2009.
DOI : 10.1016/j.ajo.2009.04.010

G. Shienbaum, O. Gupta, C. Fecarotta, A. Patel, R. Kaiser et al., Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact, American Journal of Ophthalmology, vol.153, issue.3, pp.468-473, 2012.
DOI : 10.1016/j.ajo.2011.08.011

H. Oubraham, S. Cohen, S. Samimi, D. Marotte, I. Bouzaher et al., INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED, Retina, vol.31, issue.1, pp.26-30, 2011.
DOI : 10.1097/IAE.0b013e3181de5609

K. Hatz and C. Prünte, Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study, Acta Ophthalmol (Copenh), 2016.

I. Mantel, A. Deli, K. Iglesias, and A. Ambresin, Prospective study evaluating the predictability of need for retreatment with intravitreal ranibizumab for age-related macular degeneration, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.364, issue.3, pp.697-704, 2013.
DOI : 10.1056/NEJMicm1005605

I. Mantel, S. Niderprim, C. Gianniou, A. Deli, and A. Ambresin, Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen, British Journal of Ophthalmology, vol.118, issue.9, pp.1192-1198, 2014.
DOI : 10.1016/j.ophtha.2010.12.019

J. Lu, R. Bruno, S. Eppler, W. Novotny, B. Lum et al., Clinical pharmacokinetics of bevacizumab in patients with solid tumors, Cancer Chemotherapy and Pharmacology, vol.28, issue.5, pp.779-86, 2008.
DOI : 10.1007/978-1-4899-2329-5_8

J. Gaudreault, D. Fei, J. Rusit, P. Suboc, and V. Shiu, Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration, Investigative Opthalmology & Visual Science, vol.46, issue.2, pp.726-759, 2005.
DOI : 10.1167/iovs.04-0601

M. Thulliez, D. Angoulvant, L. Lez, M. Jonville-bera, A. Pisella et al., Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies, JAMA Ophthalmology, vol.132, issue.11, pp.1317-1343, 2014.
DOI : 10.1001/jamaophthalmol.2014.2333

URL : http://archopht.jamanetwork.com/data/journals/ophth/931033/eoi140065.pdf

L. Moja, E. Lucenteforte, K. Kwag, V. Bertele, A. Campomori et al., Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration, Cochrane Database Syst Rev, vol.2, issue.2, p.11230, 2014.
DOI : 10.1016/S2214-109X(13)70145-1

R. Avery and G. Gordon, Systemic Safety of Prolonged Monthly Anti???Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema, JAMA Ophthalmology, vol.134, issue.1, pp.21-30, 2016.
DOI : 10.1001/jamaophthalmol.2015.4070

T. Ueta, Y. Noda, T. Toyama, T. Yamaguchi, and S. Amano, Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration, Ophthalmology, vol.121, issue.11, pp.2193-2203, 2014.
DOI : 10.1016/j.ophtha.2014.05.022

C. Murray, The Physiological Principle of Minimum Work: I. The Vascular System and the Cost of Blood Volume, Proceedings of the National Academy of Sciences, vol.12, issue.3, pp.207-221, 1926.
DOI : 10.1073/pnas.12.3.207

C. Murray, The Physiological Principle of Minimum Work: II. Oxygen Exchange in Capillaries, Proceedings of the National Academy of Sciences, vol.12, issue.5, pp.299-304, 1926.
DOI : 10.1073/pnas.12.5.299

C. Murray, THE PHYSIOLOGICAL PRINCIPLE OF MINIMUM WORK APPLIED TO THE ANGLE OF BRANCHING OF ARTERIES, The Journal of General Physiology, vol.9, issue.6, pp.835-876, 1926.
DOI : 10.1085/jgp.9.6.835

T. Sherman, A. Popel, A. Koller, and P. Johnson, The cost of departure from optimal radii in microvascular networks, Journal of Theoretical Biology, vol.136, issue.3, pp.245-65, 1989.
DOI : 10.1016/S0022-5193(89)80162-6

J. Less, T. Skalak, E. Sevick, and R. Jain, Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions, Cancer Res. 1 janv, vol.51, issue.1, pp.265-73, 1991.

J. Folkman, Tumor angiogenesis: therapeutic implications, N Engl J Med, vol.285, issue.21, pp.1182-1188, 1971.

H. Trau, M. Brännström, T. Curry, and D. Duffy, Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells, Human Reproduction, vol.31, issue.2, pp.436-480, 2016.
DOI : 10.1093/humrep/dev320

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-938, 2005.
DOI : 10.1053/j.seminoncol.2004.03.034

C. Drake and C. Little, Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization., Proceedings of the National Academy of Sciences, vol.92, issue.17, pp.7657-61, 1995.
DOI : 10.1073/pnas.92.17.7657

URL : http://www.pnas.org/content/92/17/7657.full.pdf

K. Hirschi, S. Rohovsky, L. Beck, S. Smith, D. Amore et al., Endothelial Cells Modulate the Proliferation of Mural Cell Precursors via Platelet-Derived Growth Factor-BB and Heterotypic Cell Contact, Circulation Research, vol.84, issue.3, pp.298-305, 1999.
DOI : 10.1161/01.RES.84.3.298

M. Hellström, H. Gerhardt, M. Kalén, X. Li, U. Eriksson et al., Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis, The Journal of Cell Biology, vol.126, issue.3, pp.543-53, 2001.
DOI : 10.1046/j.1460-9568.1999.00502.x

N. Ferrara, Pathways mediating VEGF-independent tumor angiogenesis, Cytokine & Growth Factor Reviews, vol.21, issue.1, pp.21-27, 2010.
DOI : 10.1016/j.cytogfr.2009.11.003

F. Yuan, Y. Chen, M. Dellian, N. Safabakhsh, N. Ferrara et al., Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody, Proceedings of the National Academy of Sciences, vol.55, issue.18, pp.14765-70, 1996.
DOI : 10.1146/annurev.ph.57.030195.004143

URL : http://www.pnas.org/content/93/25/14765.full.pdf

R. Tong, Y. Boucher, S. Kozin, F. Winkler, D. Hicklin et al., Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors, Cancer Research, vol.64, issue.11, pp.3731-3737, 2004.
DOI : 10.1158/0008-5472.CAN-04-0074

R. Jain, Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, Science, vol.307, issue.5706, pp.58-62, 2005.
DOI : 10.1126/science.1104819

P. Carmeliet and R. Jain, Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, Nature Reviews Drug Discovery, vol.7, issue.6, pp.417-444, 2011.
DOI : 10.1038/nmeth.1475

D. Kim, J. Fingler, R. Zawadzki, S. Park, L. Morse et al., Optical imaging of the chorioretinal vasculature in the living human eye, Proceedings of the National Academy of Sciences, vol.53, issue.1, pp.14354-14363, 2013.
DOI : 10.1167/iovs.11-8249

W. Choi, K. Mohler, B. Potsaid, C. Lu, J. Liu et al., Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography, PLoS ONE, vol.12, issue.12, p.81499, 2013.
DOI : 10.1371/journal.pone.0081499.s002

URL : https://doi.org/10.1371/journal.pone.0081499

D. Schwartz, J. Fingler, D. Kim, R. Zawadzki, L. Morse et al., Phase-Variance Optical Coherence Tomography, Ophthalmology, vol.121, issue.1, pp.180-187, 2014.
DOI : 10.1016/j.ophtha.2013.09.002

R. Spaide, J. Klancnik, and M. Cooney, Retinal Vascular Layers Imaged by Fluorescein Angiography and Optical Coherence Tomography Angiography, JAMA Ophthalmology, vol.133, issue.1, pp.45-50, 2015.
DOI : 10.1001/jamaophthalmol.2014.3616

URL : http://archopht.jamanetwork.com/data/journals/ophth/931885/eoi140088.pdf

M. Savastano, B. Lumbroso, and M. Rispoli, IN VIVO CHARACTERIZATION OF RETINAL VASCULARIZATION MORPHOLOGY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2196-203, 2015.
DOI : 10.1097/IAE.0000000000000635

M. López-sáez, E. Ordoqui, P. Tornero, A. Baeza, T. Sainza et al., Fluorescein-Induced Allergic Reaction, Annals of Allergy, Asthma & Immunology, vol.81, issue.5, pp.428-458, 1998.
DOI : 10.1016/S1081-1206(10)63140-7

R. Spaide, J. Fujimoto, and N. Waheed, IMAGE ARTIFACTS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2163-80, 2015.
DOI : 10.1097/IAE.0000000000000765

L. Kuehlewein, M. Bansal, T. Lenis, N. Iafe, S. Sadda et al., Optical Coherence Tomography Angiography of??Type 1 Neovascularization in Age-Related Macular Degeneration, American Journal of Ophthalmology, vol.160, issue.4, pp.739-748, 2015.
DOI : 10.1016/j.ajo.2015.06.030

A. Miere, G. Querques, O. Semoun, E. Ameen, V. Capuano et al., OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EARLY TYPE 3 NEOVASCULARIZATION, Retina, vol.35, issue.11, pp.2236-2277, 2015.
DOI : 10.1097/IAE.0000000000000834

A. Miere, O. Semoun, S. Cohen, E. Ameen, M. Srour et al., OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.11, pp.2275-84, 2015.
DOI : 10.1097/IAE.0000000000000819

N. Palejwala, Y. Jia, S. Gao, L. Liu, C. Flaxel et al., DETECTION OF NONEXUDATIVE CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2204-2215, 2015.
DOI : 10.1097/IAE.0000000000000867

L. Roisman, Q. Zhang, R. Wang, G. Gregori, A. Zhang et al., Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration, Ophthalmology, vol.123, issue.6, pp.1309-1328, 2016.
DOI : 10.1016/j.ophtha.2016.01.044

G. Coscas, M. Lupidi, F. Coscas, C. Cagini, and E. Souied, OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.11, pp.2219-2247, 2015.
DOI : 10.1097/IAE.0000000000000766

N. Muakkassa, A. Chin, T. De-carlo, K. Klein, C. Baumal et al., CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2252-2261, 2015.
DOI : 10.1097/IAE.0000000000000836

J. Marques, J. Costa, M. Marques, M. Cachulo, J. Figueira et al., Sequential Morphological Changes in the CNV Net after Intravitreal Anti-VEGF Evaluated with OCT Angiography, Ophthalmic Research, vol.55, issue.3, pp.145-51, 2016.
DOI : 10.1159/000442671

D. Huang, Y. Jia, M. Rispoli, O. Tan, and B. Lumbroso, OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TIME COURSE OF CHOROIDAL NEOVASCULARIZATION IN RESPONSE TO ANTI-ANGIOGENIC TREATMENT, Retina, vol.35, issue.11, pp.2260-2264, 2015.
DOI : 10.1097/IAE.0000000000000846

B. Lumbroso, M. Rispoli, M. Savastano, Y. Jia, O. Tan et al., Optical Coherence Tomography Angiography Study of Choroidal Neovascularization Early Response after Treatment, Dev Ophthalmol, vol.56, pp.77-85, 2016.
DOI : 10.1159/000442782

A. Bird, N. Bressler, S. Bressler, I. Chisholm, G. Coscas et al., An international classification and grading system for age-related maculopathy and age-related macular degeneration, Survey of Ophthalmology, vol.39, issue.5, pp.367-74, 1995.
DOI : 10.1016/S0039-6257(05)80092-X

L. Kuehlewein, S. Sadda, and D. Sarraf, OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy, Eye, vol.125, issue.7, pp.932-937, 2015.
DOI : 10.1016/j.canlet.2013.05.015

URL : http://www.nature.com/eye/journal/v29/n7/pdf/eye201580a.pdf

R. Spaide, Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization, American Journal of Ophthalmology, vol.160, issue.1, pp.6-16, 2015.
DOI : 10.1016/j.ajo.2015.04.012

W. Schierling, K. Troidl, C. Troidl, T. Schmitz-rixen, W. Schaper et al., The Role of Angiogenic Growth Factors in Arteriogenesis, Journal of Vascular Research, vol.46, issue.4, pp.365-74, 2009.
DOI : 10.1159/000189797

S. Wu, X. Wu, W. Zhu, W. Cai, J. Schaper et al., Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis, Molecular and Cellular Biochemistry, vol.274, issue.23, pp.223-232, 2010.
DOI : 10.1152/ajpheart.00478.2002

M. Potente, H. Gerhardt, and P. Carmeliet, Basic and Therapeutic Aspects of Angiogenesis, Cell, vol.146, issue.6, pp.873-87, 2011.
DOI : 10.1016/j.cell.2011.08.039

N. Reinmuth, W. Liu, Y. Jung, S. Ahmad, R. Shaheen et al., Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival, The FASEB Journal, vol.15, issue.7, pp.1239-1280, 2001.
DOI : 10.1096/fj.00-0693fje

M. Furuhashi, T. Sjöblom, A. Abramsson, J. Ellingsen, P. Micke et al., Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate, Cancer Research, vol.64, issue.8, pp.2725-2758, 2004.
DOI : 10.1158/0008-5472.CAN-03-1489

R. Jain, Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy, Nature Medicine, vol.7, issue.9, pp.987-996, 2001.
DOI : 10.1038/nm0901-987

E. Moult, W. Choi, N. Waheed, M. Adhi, B. Lee et al., Ultrahigh-Speed Swept-Source OCT Angiography in Exudative AMD, Ophthalmic Surgery, Lasers and Imaging Retina, vol.45, issue.6, pp.496-505, 2014.
DOI : 10.3928/23258160-20141118-03

Y. Jia, S. Bailey, D. Wilson, O. Tan, M. Klein et al., Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration, Ophthalmology, vol.121, issue.7, pp.1435-1479, 2014.
DOI : 10.1016/j.ophtha.2014.01.034